GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Study Completion Date
October 31, 2006
Conditions
Graft vs Host Disease
Interventions
DRUG
Infliximab
Trial Locations (1)
30322
Children's Healthcare of Atlanta/Emory University, Atlanta
All Listed Sponsors
lead
Emory University
OTHER
NCT00228839 - GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease | Biotech Hunter | Biotech Hunter